Billiontoone
BLLN91.65038.89% ( -58.320 )
Q2 FY2026 EarningsQ2 FY26 beat consensus across top and bottom lines: revenue $109.4M vs. $109.1M expected, and GAAP EPS of $0.15 vs. $0.19 expected mean (though beating the low-end). Oncology revenue surged 176% YoY, and gross margin improved to 70.0%. Management reiterated FY26 revenue guidance of $450M-$465M, in-line with the consensus mid-point, while achieving a significant swing to positive operating income of $5.5M.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Billiontoone(BLLN) the Revenue is 109.45 M (+64.4%);the EBIT is 5.503 M (+438.2%);the EPS is 0.15 (+733.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.11B64.40%
----
----
EBIT
0.01B438.23%
----
----
EPS
0.15733.23%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf